Results 171 to 180 of about 3,843,014 (290)

Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure. [PDF]

Open Heart
Hlavacek D, Cinkajzlova A, Kollar M, Kasperova BJ, Melenovsky V, Mraz M, Haluzik M, Ivak P, Stemberkova Hubackova S.   +8 more
europepmc   +1 more source

Gamma suppression correlates with thalamic stimulation therapeutic response in intractable epilepsy

Epilepsia, EarlyView.
Abstract Objective In patients with drug‐resistant epilepsy who undergo anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS), efficacy is assessed months after therapy initiation and clinicians have no guidance when choosing stimulation parameters due to the lack of real‐time biomarkers.
Zachary T. Sanger, Xinbing Zhang, Thomas Lisko, Hafsa Farooqi, Steffen Ventz, Sandipan Pati, Thomas R. Henry, David P. Darrow, Michael C. Park, Theoden I. Netoff, Robert A. McGovern   +10 more
wiley   +1 more source

Left Ventricular Assist Device Followed by Heart Transplantation

Arquivos Brasileiros de Cardiologia, 2015
Bruno Biselli, Silvia Moreira Ayub-Ferreira, Monica Samuel Avila, Fábio Antonio Gaiotto, Fabio Biscegli Jatene, Edimar Alcides Bocchi   +5 more
doaj   +1 more source

Cerebral hemorrhage after left ventricular assist device implantation in a patient with dilated cardiomyopathy: a case report. [PDF]

Front Cardiovasc Med
Wei Y, Zhang Y, Han L, Zhang A, Jing R.
europepmc   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Carotid Stenting in a Patient With Syncope and Left Ventricular Assist Device Placement. [PDF]

JACC Case Rep
Sheikh OA, Wong GX, Gill KM, Shishehbor MH.   +3 more
europepmc   +1 more source

Spike detection in the wild: Screening of suspected temporal lobe epilepsy cases using a tailored 2‐channel wearable EEG

Epilepsia Open, EarlyView.
Abstract Objective To clinically validate the contribution of a custom‐built EEG wearable device (waEEG) compared to a full 10–20 electrode array ambulatory EEG (aEEG) for screening epilepsy cases in patients with suspected temporal lobe epilepsy (TLE) but negative routine EEGs. Methods Patients (aged 16–91 years) with clinically suspected TLE who were
Daniel Filipe Borges, Joana Isabel Soares, Daniela Dias, Helena Cordeiro, Alberto Leal   +4 more
wiley   +1 more source

PERM1 Is Selectively Restored in Left Ventricular Assist Device-Mediated Myocardial Recovery in Heart Failure. [PDF]

J Am Heart Assoc
Sreedevi K, Shankar TS, Zaitsev AV, Korte A, Tseliou E, Kyriakoulis I, Selzman CH, Drakos SG, Warren JS.   +8 more
europepmc   +1 more source

Exercising electrocardiograms from Thoroughbred racehorses with exercise associated sudden death

Equine Veterinary Journal, EarlyView.
Abstract Background Exercise associated sudden death (EASD), defined as a fatal collapse in a closely monitored and previously presumed clinically healthy horse that occurs during exercise or within approximately 1 h after exercise, is disproportionately more common in equine than in human athletes.
Cristobal Navas de Solis, M. Durando, L. Nath, S. Durward‐Akhurst   +3 more
wiley   +1 more source

Intragastric driveline transposition of a left ventricular assist device: a case report. [PDF]

J Surg Case Rep
Stöffler L, Cholevas N, Potapov E, Schöning W.   +3 more
europepmc   +1 more source